PPLPHARMA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Piramal Pharma Ltd

Watchlist Manager

Watchlist

Price: 175.65 INR -1.8%

Market Cap: ₹232.7B

P	Piramal Pharma Ltd NSE:PPLPHARMA	IN
S	Seatrium Limited SWB:S8N	SG
	Hoya Corp OTC:HOCPF	JP

Profitability Summary

Piramal Pharma Ltd's profitability score is 41/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

63%

Gross Margin is Increasing

59% > 65%

Low Operating Margin

Sustainable 3Y Average Operating Margin

14%

Declining Operating Margin

16% > 2%

Negative Net Margin

-2%

Low 3Y Average Net Margin

Net Margin is Increasing

-3% > -2%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

View All

Hide

Collapse

41 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.